Csenge Advisory Group Invests $646,000 in Axon Enterprise, Inc $AXON

Csenge Advisory Group purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,152 shares of the biotechnology company’s stock, valued at approximately $646,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise in the 4th quarter worth about $28,000. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $30,000. AlphaCentric Advisors LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $34,000. Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise in the second quarter valued at approximately $37,000. Finally, Strive Financial Group LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $41,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AXON has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. JPMorgan Chase & Co. increased their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Barclays raised their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Morgan Stanley boosted their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $730.92.

Insider Activity

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 564 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $478.97, for a total transaction of $270,139.08. Following the sale, the director owned 3,632 shares of the company’s stock, valued at approximately $1,739,619.04. This trade represents a 13.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the sale, the executive directly owned 49,710 shares in the company, valued at approximately $24,855,000. The trade was a 2.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 68,989 shares of company stock valued at $36,016,932 over the last 90 days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $645.72 on Thursday. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $794.29. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The firm has a market capitalization of $52.46 billion, a PE ratio of 267.93, a price-to-earnings-growth ratio of 10.06 and a beta of 1.39. The business’s fifty day moving average price is $536.03 and its 200 day moving average price is $474.89.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same period in the prior year, the firm posted $2.12 EPS. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.